Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-23A Randomized, Open-label, Two-period, Crossover, Steady-state Bioequivalence Study of Aripiprazole for Injection Following Multiple Dosing in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-04-23A Phase 3, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-04-23Database Registry to Examine Brain Connections and Brain Function in Mental Disorders and Neural Network Biomarkers for Relational Memory and Psychosis in Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-04-22Luteolin for the Treatment of People With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-04-22Accelerated Transcranial Magnetic Stimulation in Psychotic Disorders
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-22Deep rTMS Modulating Insula Synaptic Density and Smoking Behavior in Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-04-22An Open-Label Study to Assess the Long-Term Safety, Tolerability, and Effectiveness of ML-007C-MA in Adult Participants With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-04-21Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders
-
CLINICAL_TRIALS study record update · 2026-04-21Comparison of Venous Tourniquet Method With Isolated Forearm Technique in Electroconvulsive Therapy in Terms of Efficacy and Safety
-
CLINICAL_TRIALS study record update · 2026-04-20A Prospective, Dose Escalating, Open Label, Multi-center, Phase I/IIa Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine.
-
CLINICAL_TRIALS study record update · 2026-04-20Structural and Functional Imaging of Neuropsychiatric Patients and Normal Volunteers With 3.0 Tesla MRI and Magnetoencephalography (MEG)
-
CLINICAL_TRIALS study record update · 2026-04-17A Phase 2 Multicenter, Double-Blind, Parallel-Arm Study to Investigate the Efficacy and Safety of Adjunctive Treatment With Brenipatide in Adult Participants With Schizophrenia (RENEW-Scz-1)
-
CLINICAL_TRIALS study record update · 2026-04-16A Phase 4, Open-Label Study to Evaluate the Efficacy of Valbenazine on Clinician- and Patient-Reported Outcomes in Patients With Tardive Dyskinesia (TD) Who Remain Symptomatic While on Deutetrabenazine or After Discontinuing Prior TD Treatment With a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
-
CLINICAL_TRIALS study record update · 2026-04-16Examining the Efficacy of a Virtual Reality Cognitive Remediation Program for People Living With Psychosis
-
CLINICAL_TRIALS study record update · 2026-04-15A Phase 3, Multicenter, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Assess the Efficacy of NBI-1117568 in Preventing Relapse of the Symptoms of Schizophrenia and to Assess the Safety and Tolerability of NBI-1117568 in Adults With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-04-15A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-1117570 in Adults With Schizophrenia Who Warrant Inpatient Hospitalization
-
CLINICAL_TRIALS study record update · 2026-04-15Enhancing Veteran-Clinical Collaboration in VA Psychosocial Rehabilitation and Recovery Centers
-
CLINICAL_TRIALS study record update · 2026-04-15A Global, Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NBI-1117568 in Adults With Schizophrenia Who Warrant Inpatient Hospitalization
-
CLINICAL_TRIALS study record update · 2026-04-15A Global, Phase 3, Multicenter, Open-Label Study to Assess the Long-Term Safety and Tolerability of NBI-1117568 in Adults With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-04-14The Effect of Adjuvant Curcumin Extract on Quality of Life and Interleukin-1 Beta (IL-1β) Levels in Patients With Schizophrenia Receiving Risperidone: A Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2026-04-14Risk of Breakthrough Symptoms On Antipsychotic Maintenance Medication When Remitted Patients Are Treated With Long-Acting Injectable Medications
-
CLINICAL_TRIALS study record update · 2026-04-13A Randomized, Double-blind, Placebo-controlled Study to Determine Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
-
CLINICAL_TRIALS study record update · 2026-04-13Effectiveness and Adverse-effect Switch Evaluation
-
CLINICAL_TRIALS study record update · 2026-04-13Accelerated Neuromodulation of Prefrontal Circuitry During Clozapine Treatment
-
CLINICAL_TRIALS study record update · 2026-04-13A Randomized, Double-blinded, Placebo-controlled, Multicenter Study to Evaluate the Antipsychotic Efficacy and Safety of LB 102 in the Treatment of Adult Patients With Acute Schizophrenia